help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on June 26, 2008
Endocrinology, doi:10.1210/en.2007-1528
A more recent version of this article appeared on October 1, 2008
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
149/10/4883    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nakamura, K.
Right arrow Articles by Tanoue, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nakamura, K.
Right arrow Articles by Tanoue, A.

Submitted on November 6, 2007
Accepted on June 13, 2008

Effects of vasopressin V1b receptor deficiency on ACTH release from anterior pituitary cells in response to oxytocin stimulation

Kazuaki Nakamura, Yoko Fujiwara, Reiko Mizutani, Atsushi Sanbe, Noriko Miyauchi, Masami Hiroyama, Junji Yamauchi, Tatsuya Yamashita, Shigeki Nakamura, Toyoki Mori, Gozoh Tsujimoto, and Akito Tanoue*

Department of Pharmacology, National Research Institute for Child Health and Development (K.N., Y.F., R.M., A.S., N.M., M.H., J.Y., A.T.), 2-10-1 Okura, Setagaya-ku, Tokyo 157-8535, Japan; Department of Genomic Drug Discovery Science, Graduate School of Pharmaceutical Sciences, Kyoto University Faculty of Pharmaceutical Sciences, Kyoto University (G.T.), Yoshida Shimoadachi-cho, Sakyo-ku, Kyoto 606-8501, Japan; and Otsuka Pharmaceutical Co., Ltd. (T.Y., S.N., T.M.), 463-10 Kagasuno, Kawauchi-cho Tokushima 771-0192, Japan

* To whom correspondence should be addressed. E-mail: atanoue{at}nch.go.jp.

Oxytocin (OT) is one of the secretagogues for stress-induced adrenocorticotropoic hormone (ACTH) release. OT-induced ACTH release is reported to be mediated by the vasopressin V1b receptor in the rat pituitary gland, which contains both OT and V1b receptors. We examined OT-induced ACTH release using primary cultures of anterior pituitary cells from wild-type (V1bR+/+) and V1b receptor knockout (V1bR-/-) mice. OT stimulated similar levels of ACTH release from pituitary cells of V1bR+/+ and V1bR-/- mice. OT-induced ACTH release was significantly inhibited by the selective V1b receptor antagonist SSR149415 and by the OT receptor antagonist CL-14–26 in V1bR+/+ mice. In addition, co-treatment with SSR149415 at 10-6 M and CL-14–26 at 10-6 M inhibited OT-induced ACTH release to the control level in V1bR+/+ mice. In V1bR-/- mice, OT-induced ACTH release was significantly inhibited by CL-14–26 at 10-8 M and completely inhibited at 10-7 M. These results indicate that OT induces the ACTH response via OT and V1b receptors in V1bR+/+ mice but via only OT receptors in V1bR-/- mice. The gene expression level of the OT receptor was significantly higher in the anterior pituitary gland of V1bR-/- mice than in that of V1bR+/+ mice, suggesting that the OT receptor is up-regulated to compensate for ACTH release under conditions of V1b receptor deficiency.


Key words: V1b receptor • ACTH • oxytocin







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2008 by The Endocrine Society